These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 39046728)
1. Social Vulnerability and Prevalence and Treatment for Mental Health and Substance Use Disorders. Gibbons RD; Olfson M; Saulsberry L; Edlund MJ; Zangeneh S; Bareis N; Chwastiak L; Gibbons JB; Kessler RC JAMA Psychiatry; 2024 Oct; 81(10):976-984. PubMed ID: 39046728 [TBL] [Abstract][Full Text] [Related]
2. Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration. Lin LA; Bohnert ASB; Blow FC; Gordon AJ; Ignacio RV; Kim HM; Ilgen MA Addiction; 2021 Jan; 116(1):96-104. PubMed ID: 32428386 [TBL] [Abstract][Full Text] [Related]
3. Childhood sexual abuse and psychiatric disorders in middle-aged and older adults: evidence from the 2007 Adult Psychiatric Morbidity Survey. Chou KL J Clin Psychiatry; 2012 Nov; 73(11):e1365-71. PubMed ID: 23218165 [TBL] [Abstract][Full Text] [Related]
4. Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States. Hasin DS; Sarvet AL; Meyers JL; Saha TD; Ruan WJ; Stohl M; Grant BF JAMA Psychiatry; 2018 Apr; 75(4):336-346. PubMed ID: 29450462 [TBL] [Abstract][Full Text] [Related]
5. Correlates of specialty substance use treatment among adults with opioid use disorders. Romo E; Ulbricht CM; Clark RE; Lapane KL Addict Behav; 2018 Nov; 86():96-103. PubMed ID: 29551551 [TBL] [Abstract][Full Text] [Related]
6. Association of psychiatric and substance use disorders with cannabis use and cannabis use disorder during early pregnancy in northern California. Young-Wolff KC; Chi FW; Campbell CI; Does MB; Brown QL; Alexeeff SE; Ansley D; Wang X; Lapham GT Addiction; 2024 Nov; 119(11):1987-1997. PubMed ID: 39082097 [TBL] [Abstract][Full Text] [Related]
7. Epidemiology of DSM-5 Drug Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III. Grant BF; Saha TD; Ruan WJ; Goldstein RB; Chou SP; Jung J; Zhang H; Smith SM; Pickering RP; Huang B; Hasin DS JAMA Psychiatry; 2016 Jan; 73(1):39-47. PubMed ID: 26580136 [TBL] [Abstract][Full Text] [Related]
8. Association of Borderline Personality Disorder Criteria With Suicide Attempts Among US Adults. Grilo CM; Udo T JAMA Netw Open; 2021 May; 4(5):e219389. PubMed ID: 33974054 [TBL] [Abstract][Full Text] [Related]
9. Functional and structural social support, substance use and sexual orientation from a nationally representative sample of US adults. Kahle EM; Veliz P; McCabe SE; Boyd CJ Addiction; 2020 Mar; 115(3):546-558. PubMed ID: 31599027 [TBL] [Abstract][Full Text] [Related]
10. Pre-enlistment Anger Attacks and Postenlistment Mental Disorders and Suicidality Among US Army Soldiers. Smith DM; Meruelo A; Campbell-Sills L; Sun X; Kessler RC; Ursano RJ; Jain S; Stein MB; JAMA Netw Open; 2021 Sep; 4(9):e2126626. PubMed ID: 34570207 [TBL] [Abstract][Full Text] [Related]
11. Medical Multimorbidity, Mental Illness, and Substance Use Disorder among Middle-Aged and Older Justice-Involved Adults in the USA, 2015-2018. Han BH; Williams BA; Palamar JJ J Gen Intern Med; 2021 May; 36(5):1258-1263. PubMed ID: 33051837 [TBL] [Abstract][Full Text] [Related]
12. Patient and Health Care Factors Associated With Long-term Diabetes Complications Among Adults With and Without Mental Health and Substance Use Disorders. Schmidt EM; Barnes J; Chen C; Trafton J; Frayne S; Harris AHS JAMA Netw Open; 2019 Sep; 2(9):e1912060. PubMed ID: 31553472 [TBL] [Abstract][Full Text] [Related]
13. Multiple DSM-5 substance use disorders: A national study of US adults. McCabe SE; West BT; Jutkiewicz EM; Boyd CJ Hum Psychopharmacol; 2017 Sep; 32(5):. PubMed ID: 28750478 [TBL] [Abstract][Full Text] [Related]
14. Cannabis Use and Risk of Psychiatric Disorders: Prospective Evidence From a US National Longitudinal Study. Blanco C; Hasin DS; Wall MM; Flórez-Salamanca L; Hoertel N; Wang S; Kerridge BT; Olfson M JAMA Psychiatry; 2016 Apr; 73(4):388-95. PubMed ID: 26886046 [TBL] [Abstract][Full Text] [Related]
15. DSM-5 cannabis use disorder, substance use and DSM-5 specific substance-use disorders: Evaluating comorbidity in a population-based sample. Hayley AC; Stough C; Downey LA Eur Neuropsychopharmacol; 2017 Aug; 27(8):732-743. PubMed ID: 28663122 [TBL] [Abstract][Full Text] [Related]
16. Predictors of mental health and substance use disorder treatment use over 3 years among rural adults using stimulants. Cucciare MA; Ounpraseuth ST; Curran GM; Booth BM Subst Abus; 2019; 40(3):363-370. PubMed ID: 30810499 [No Abstract] [Full Text] [Related]
17. Trends in and Characteristics of Buprenorphine Misuse Among Adults in the US. Han B; Jones CM; Einstein EB; Compton WM JAMA Netw Open; 2021 Oct; 4(10):e2129409. PubMed ID: 34652446 [TBL] [Abstract][Full Text] [Related]
18. Substance use and treatment of substance use disorders in a community sample of transgender adults. Keuroghlian AS; Reisner SL; White JM; Weiss RD Drug Alcohol Depend; 2015 Jul; 152():139-46. PubMed ID: 25953644 [TBL] [Abstract][Full Text] [Related]
19. Psychiatric Symptoms, Treatment Uptake, and Barriers to Mental Health Care Among US Adults With Post-COVID-19 Condition. Naik H; Tran KC; Staples JA; Perlis RH; Levin A JAMA Netw Open; 2024 Apr; 7(4):e248481. PubMed ID: 38662370 [TBL] [Abstract][Full Text] [Related]